MedHab, LLC – Trademark Portfolio

Entity Type: 16

MedHab, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RPM2, MYNOTIFI, and STEPRITE. The owner is based in Mansfield, TX.

3216 Essex Drive

Mansfield, TX 76063

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MedHab, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does MedHab, LLC have?

MedHab, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned.

What trademark classes does MedHab, LLC file in?

MedHab, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 25 (Clothing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MedHab, LLC's most well-known trademarks?

MedHab, LLC's registered trademark portfolio includes well-known marks such as RPM2, MYNOTIFI, and STEPRITE. These are among 3 currently registered trademarks in the portfolio.

What is MedHab, LLC's trademark registration success rate?

MedHab, LLC has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.